Richard T. Davey
About
Richard T. Davey is a scholar working on Infectious Diseases, Virology and Epidemiology.
According to data from OpenAlex, Richard T. Davey has authored 170 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Infectious Diseases, 91 papers in Virology and 62 papers in Epidemiology. Recurrent topics in Richard T. Davey's work include HIV Research and Treatment (91 papers), HIV/AIDS Research and Interventions (49 papers) and HIV/AIDS drug development and treatment (47 papers). Richard T. Davey is often cited by papers focused on HIV Research and Treatment (91 papers), HIV/AIDS Research and Interventions (49 papers) and HIV/AIDS drug development and treatment (47 papers). Richard T. Davey collaborates with scholars based in United States, United Kingdom and Australia. Richard T. Davey's co-authors include H. Clifford Lane, Joseph A. Kovacs, Julia A. Metcalf, Michael A. Polis, Henry Masur, Judith Falloon, Anthony S. Fauci, Robin Dewar, Michael Baseler and Robert Walker and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
In The Last Decade
Richard T. Davey
169 papers receiving 11.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Richard T. Davey United States | 56 | 6.3k | 6.2k | 3.5k | 3.2k | 1.2k | 170 | 11.8k | ||
| Ian Frank United States | 53 | 3.9k 0.6× | 3.5k 0.6× | 2.8k 0.8× | 2.9k 0.9× | 2.0k 1.7× | 157 | 9.5k | ||
| Anders Sönnerborg Sweden | 51 | 5.3k 0.8× | 4.5k 0.7× | 2.4k 0.7× | 2.5k 0.8× | 1.1k 0.9× | 324 | 9.2k | ||
| Benigno Rodríguez United States | 46 | 6.6k 1.1× | 4.6k 0.7× | 3.6k 1.0× | 3.0k 0.9× | 1.1k 0.9× | 149 | 11.0k | ||
| Joep M. A. Lange Netherlands | 62 | 9.3k 1.5× | 9.2k 1.5× | 2.4k 0.7× | 3.3k 1.0× | 805 0.7× | 293 | 14.2k | ||
| Timothy W. Schacker United States | 55 | 10.3k 1.6× | 6.3k 1.0× | 6.5k 1.8× | 4.3k 1.3× | 1.5k 1.2× | 119 | 15.3k | ||
| Michael A. Polis United States | 43 | 4.3k 0.7× | 3.5k 0.6× | 2.8k 0.8× | 2.9k 0.9× | 656 0.5× | 143 | 8.6k | ||
| Cécile Goujard France | 49 | 5.0k 0.8× | 4.0k 0.6× | 2.8k 0.8× | 2.0k 0.6× | 649 0.5× | 230 | 8.2k | ||
| Rajesh T. Gandhi United States | 46 | 4.2k 0.7× | 5.5k 0.9× | 2.1k 0.6× | 2.3k 0.7× | 863 0.7× | 164 | 9.8k | ||
| Eric S. Daar United States | 55 | 7.2k 1.1× | 7.3k 1.2× | 1.6k 0.4× | 2.9k 0.9× | 815 0.7× | 239 | 11.5k | ||
| Alfred J. Saah United States | 57 | 4.8k 0.8× | 5.3k 0.9× | 2.7k 0.8× | 6.4k 2.0× | 856 0.7× | 165 | 13.6k |
Countries citing papers authored by Richard T. Davey
Since
Specialization
Citations
This map shows the geographic impact of Richard T. Davey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard T. Davey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard T. Davey more than expected).
Fields of papers citing papers by Richard T. Davey
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Richard T. Davey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard T. Davey. The network helps show where Richard T. Davey may publish in the future.
Co-authorship network of co-authors of Richard T. Davey
This figure shows the co-authorship network connecting the top 25 collaborators of Richard T. Davey. A scholar is included among the top collaborators of Richard T. Davey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard T. Davey. Richard T. Davey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Davey, Richard T., et al.. (2025). Recruiting and Consenting Decentralized Clinical Trial Participants—Learnings from the Trials@Home RADIAL Proof‐of‐Concept Trial. Clinical Pharmacology & Therapeutics. 118(5). 1067–1078.
2.
Vanderven, Hillary A., Deborah Wentworth, Win Min Han, et al.. (2023). Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza. JCI Insight. 8(14).
3.
Ko, Sung Hee, Elham Bayat Mokhtari, Prakriti Mudvari, et al.. (2021). High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19. PLoS Pathogens. 17(4). e1009431–e1009431.
4.
Burbelo, Peter D., Francis X. Riedo, Chihiro Morishima, et al.. (2020). Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019. The Journal of Infectious Diseases. 222(2). 206–213.
5.
Bhadelia, Nahid, Lauren Sauer, Theodore J. Cieslak, et al.. (2019). Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines. Health Security. 17(1). 46–53.
6.
Colombo, Rhonda E, Lori E. Dodd, Sally Hunsberger, et al.. (2015). A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase®) in adult subjects with well-controlled asthma. BMC Infectious Diseases. 16(1). 54–54.
7.
Saira, Kazima, Xudong Lin, Jay V. DePasse, et al.. (2013). Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus. UCL Discovery (University College London).
8.
Sherman, Amy C, Nirupama Trehanpati, Marybeth Daucher, et al.. (2012). Augmentation of Hepatitis B Virus-Specific Cellular Immunity with Programmed Death Receptor-1/Programmed Death Receptor-L1 Blockade in Hepatitis B Virus and HIV/Hepatitis B Virus Coinfected Patients Treated with Adefovir. AIDS Research and Human Retroviruses. 29(4). 665–672.
9.
Tavel, Jorge A., Chiung‐Yu Huang, Julia A. Metcalf, et al.. (2010). Interferon-α Produces Significant Decreases in HIV Load. Journal of Interferon & Cytokine Research. 30(7). 461–464.
10.
Jahrling, Peter B., et al.. (2009). Triage and Management of Accidental Laboratory Exposures to Biosafety Level-3 and -4 Agents. Biosecurity and Bioterrorism Biodefense Strategy Practice and Science. 7(2). 135–143.
11.
Tilton, John C., Maura Manion, Marlise R. Luskin, et al.. (2008). Human Immunodeficiency Virus Viremia Induces Plasmacytoid Dendritic Cell Activation In Vivo and Diminished Alpha Interferon Production In Vitro. Journal of Virology. 82(8). 3997–4006.
12.
Davey, Richard T., Peter Pertel, Alice Benson, et al.. (2008). Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy. Journal of Interferon & Cytokine Research. 28(2). 89–100.
13.
Hahn, Barbara, Catherine Rehm, Joseph W. Adelsberger, et al.. (2008). The Effect of Continuous Versus Pericycle Antiretroviral Therapy on IL-2 Responsiveness. Journal of Interferon & Cytokine Research. 28(7). 455–462.
14.
Kovacs, Joseph A., Susan Vogel, Randy Stevens, et al.. (2001). Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy. European Journal of Immunology. 31(5). 1351–1360.
15.
Douek, Daniel C., Michael R. Betts, Brenna J. Hill, et al.. (2001). Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection. The Journal of Immunology. 167(11). 6663–6668.
16.
Kovacs, Joseph A., Hiromi Imamichi, Susan Vogel, et al.. (2000). Effects of Intermittent Interleukin‐2 Therapy on Plasma and Tissue Human Immunodeficiency Virus Levels and Quasi‐Species Expression. The Journal of Infectious Diseases. 182(4). 1063–1069.
17.
Dybul, Mark, Michael Belson, Claire W. Hallahan, et al.. (2000). CD40 Ligand Trimer and IL-12 Enhance Peripheral Blood Mononuclear Cells and CD4+ T Cell Proliferation and Production of IFN-γ in Response to p24 Antigen in HIV-Infected Individuals: Potential Contribution of Anergy to HIV-Specific Unresponsiveness. The Journal of Immunology. 165(3). 1685–1691.
18.
Ruxrungtham, Kiat, Surapol Suwanagool, Jorge A. Tavel, et al.. (2000). A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand. AIDS. 14(16). 2509–2513.
19.
Kovacs, Joseph A., M. B. Vasudevachari, Richard T. Davey, et al.. (1993). Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.. Journal of Clinical Investigation. 92(2). 919–928.
20.
Zunich, Kathryn M., H. Clifford Lane, Richard T. Davey, et al.. (1992). Phase I/II Studies of the Toxicity and Immunogenicity of Recombinant gp160 and p24 Vaccines in HIV-Infected Individuals. AIDS Research and Human Retroviruses. 8(8). 1335–1335.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ian Frank Breakdown of academic impact, for papers by Anders Sönnerborg Breakdown of academic impact, for papers by Benigno Rodríguez Breakdown of academic impact, for papers by Joep M. A. Lange Breakdown of academic impact, for papers by Timothy W. Schacker Breakdown of academic impact, for papers by Michael A. Polis Breakdown of academic impact, for papers by Cécile Goujard Breakdown of academic impact, for papers by Rajesh T. Gandhi Breakdown of academic impact, for papers by Eric S. Daar Breakdown of academic impact, for papers by Alfred J. Saah